| Nanoparticles for immune cytokine TRAIL-based cancer therapy PPG Guimarães, S Gaglione, T Sewastianik, RD Carrasco, R Langer, ... ACS nano 12 (2), 912-931, 2018 | 122 | 2018 |
| Nanomaterial interactions with human neutrophils PW Bisso, S Gaglione, PPG Guimarães, MJ Mitchell, R Langer ACS biomaterials science & engineering 4 (12), 4255-4265, 2018 | 54 | 2018 |
| Antigen identification and high-throughput interaction mapping by reprogramming viral entry CS Dobson, AN Reich, S Gaglione, BE Smith, EJ Kim, J Dong, L Ronsard, ... Nature methods 19 (4), 449-460, 2022 | 40 | 2022 |
| Challenges to sustainable immunization systems in Gavi transitioning countries T Cernuschi, S Gaglione, F Bozzani Vaccine 36 (45), 6858-6866, 2018 | 35 | 2018 |
| Perfect adaptation of CD8+ T cell responses to constant antigen input over a wide range of affinities is overcome by costimulation N Trendel, P Kruger, S Gaglione, J Nguyen, J Pettmann, ED Sontag, ... Science signaling 14 (666), eaay9363, 2021 | 27 | 2021 |
| Advances in pediatric reference intervals for biochemical markers: Establishment of the CALIPER database in healthy children and adolescents K Karbasy, P Ariadne, S Gaglione, M Nieuwesteeg, K Adeli Journal of Medical Biochemistry 34 (1), 23, 2015 | 19 | 2015 |
| Viral targeting of hematopoietic stem cells M Birnbaum, C Dobson, S Gaglione, K Roybal, C Burnett US Patent App. 17/722,312, 2022 | | 2022 |
| Phenotypic models of perfect adaptation by CD8+ T cells SA Gaglione University of Oxford, 2019 | | 2019 |
Robert LangerMassachusetts Institute of TechnologyVerified email at mit.edu
